共 6 条
[1]
Efficacy and safety of TNF-blocker therapy in systemic lupus erythematosus[J] Aringer;Smolen Expert Opinion on Drug Safety 2008,
[2]
High-Dose Intravenous Immunoglobulins: An Option in the Treatment of Systemic Lupus Erythematosus[J] E. Toubi;A. Kessel;Y. Shoenfeld Human Immunology 2005,
[3]
High-dose azathioprine pulse therapy as a new treatment option in patients with active Wegener’s granulomatosis and lupus nephritis refractory or intolerant to cyclophosphamide[J] E. Benenson;J. W. U. Fries;B. Heilig;M. Pollok;A. Rubbert Clinical Rheumatology 2005,
[4]
Intravenous immunoglobulin and the kidney—a two-edged sword[J] Hedi Orbach;Moshe Tishler;Yehuda Shoenfeld Seminars in Arthritis and Rheumatism 2004,
[5]
Treatment with cyclophosphamide delays the progression of chronic lesions more effectively than does treatment with azathio-prine plus methylprednisolone in patients with prolifera-tive lupus nephritis Grootscholten C;Bajema IM;Florquin S;et al; Arthritis Rheum 2007,
[6]
Kidney transplanta-tioninlupus patients:a case-control study froma single cen-tre Lionaki S;Kapitsinou PP;Iniotaki A;et al; Lupus 2008,